Oxygenta Pharma files 33rd Annual Report for FY 2025-26, AGM on Aug 21
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Oxygenta Pharmaceutical Limited filed its 33rd Annual Report for FY 2025-26 with BSE. The 33rd AGM is scheduled for August 21, 2026 at 10:30 AM via video conferencing. Key resolutions include appointment of a new Whole-Time Director at Rs 6 to 8 lakh per month, a new Independent Director for 5 years, and approval of material related party transactions with holding company Virupaksha Organics Limited up to Rs 250 crore for sales and purchases and Rs 200 crore for loans and guarantees in FY 2026-27.
Shareholders to vote on new director appointments and related party deals up to Rs 450 crore with holding firm Virupaksha Organics at Aug 21 AGM.